Altered drug metabolism during pregnancy: Hormonal regulation of drug-metabolizing enzymes

Expert Opinion on Drug Metabolism and Toxicology

Volumn 6, Issue 6, 2010, Pages 689-699

  Jeong, Hyunyoung ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

CYP; Drug metabolism; Hormones; Pregnancy

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; ATENOLOL; CONSTITUTIVE ANDROSTANE RECEPTOR; CORTICOTROPIN RELEASING FACTOR; DRUG METABOLIZING ENZYME; ESTETROL; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A4; GROWTH HORMONE; HEPATOCYTE NUCLEAR FACTOR; HUMAN PLACENTA LACTOGEN; HYDROCORTISONE; LABETALOL; LAMOTRIGINE; MORPHINE; NICOTINE; PLACENTAL GROWTH HORMONE; PREGNANE X RECEPTOR; PROGESTERONE; PROLACTIN; STAT5B PROTEIN; TRANSCORTIN; UNCLASSIFIED DRUG; VALPROIC ACID; DRUG; HORMONE;

BINDING AFFINITY; CONCENTRATION RESPONSE; DRUG CLEARANCE; DRUG DISPOSITION; DRUG METABOLISM; ESTRADIOL BLOOD LEVEL; ESTRIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; ESTRONE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HORMONAL REGULATION; HUMAN; LIVER METABOLISM; MATERNAL BLOOD; NONHUMAN; PREGNANCY; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; STRUCTURE ANALYSIS; ANIMAL; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; LIVER; METABOLISM; PHYSIOLOGY;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HORMONES; HUMANS; LIVER; PHARMACEUTICAL PREPARATIONS; PREGNANCY;

EID: 77952572759     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425251003677755     Document Type: Review

References (98)

1. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191(2):398-407
2. Glover DD, Amonkar M, Rybeck BF, et al. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 2003;188(4):1039-45
3. Tatum WO, Liporace J, Benbadis SR, et al. Updates on the treatment of epilepsy in women. Arch Intern Med 2004;164(2):137-45
4. Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 2006;107(5):1120-38
5. Dombrowski MP, Schatz M. ACOG practice bulletin: clinical management guidelines for obstetrician gynecologists number 90, February 2008: asthma in pregnancy. Obstet Gynecol 2008;111(2 Pt 1):457-64
6. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005;294(21):2751-7
7. Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005;44(10):989-1008 • Review of altered drug disposition during pregnancy.
8. Dawes M, Chowienczyk PJ. Drugs in pregnancy. Pharmacokinetics in pregnancy. Best Pract Res Clin Obstet Gynaecol 2001;15(6):819-26
9. Hodge LS, Tracy TS. Alterations in drug disposition during pregnancy: implications for drug therapy. Expert Opin Drug Metab Toxicol 2007;3(4):557-71 • Review of altered drug disposition during pregnancy.
10. Best BM, Mirochnick M, Capparelli EV, et al. Impact of pregnancy on abacavir pharmacokinetics. AIDS 2006;20(4):553-60
11. Notarianni LJ. Plasma protein binding of drugs in pregnancy and in neonates. Clin Pharmacokinet 1990;18(1):20-36
12. Israili ZH, Dayton PG. Human alpha-1-glycoprotein and its interactions with drugs. Drug Metab Rev 2001;33(2):161-235
13. Baylis C. Glomerular ultrafiltration in the pseudopregnant rat. Am J Physiol 1982;243(3):F300-5
14. Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997;33(5):328-43
15. Little BB. Pharmacokinetics during pregnancy: evidence-based maternal dose formulation. Obstet Gynecol 1999;93(5 Pt 2):858-68
16. Hebert MF, Carr DB, Anderson GD, et al. Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol 2005;45(1):25-33
17. Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applications. 2nd edition. Philadelphia: Lea & Febiger, 1989
18. Nakai A, Sekiya I, Oya A, et al. Assessment of the hepatic arterial and portal venous blood flows during pregnancy with Doppler ultrasonography. Arch Gynecol Obstet 2002;266(1):25-9
19. Dempsey D, Jacob P III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002;301(2):594-8
20. Gerdin E, Salmonson T, Lindberg B, et al. Maternal kinetics of morphine during labour. J Perinat Med 1990;18(6):479-87
21. Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003;61(6 Suppl 2):S35-42
22. Anderson GD. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt) 2005;14(1):19-29
23. Shimada T, Yamazaki H, Mimura M, et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270(1):414-23
24. Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 2000;40:581-616
25. Hollenberg PF. Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug Metab Rev 2002;34(1-2):17-35
26. Honkakoski P, Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J 2000;347(Pt 2):321-37
27. Urquhart BL, Tirona RG, Kim RB. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 2007;47(5):566-78
28. Honkakoski P, Zelko I, Sueyoshi T, et al. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 1998;18(10):5652-8
29. di Masi A, Marinis ED, Ascenzi P, et al. Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. Mol Aspects Med 2009;30(5):297-343
30. Dixit SG, Tirona RG, Kim RB. Beyond CAR and PXR. Curr Drug Metab 2005;6(4):385-97
31. Cunningham FG. Williams obstetrics. 21st edition. McGraw-Hill Medical Publishing Division, New York; 2001
32. Holinka CF, Diczfalusy E, Coelingh Bennink HJ. Estetrol: a unique steroid in human pregnancy. J Steroid Biochem Mol Biol 2008;110(1-2):138-43
33. Jeong H, Choi S, Song JW, et al. Regulation of UDP- glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination. Xenobiotica 2008;38(1):62-75
34. Chen H, Yang K, Choi S, et al. Upregulation of UDP- glucuronosyltransferase (UGT) 1A4 by 17{beta}-Estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy. Drug Metab Dispos 2009;37(9):1841-7
35. Koh K, Jeong H. Effects of 17beta-estradiol (E2) on expression of CYP enzymes in human hepatocytes. Drug Metab Rev 2009;41(Suppl 3):49
36. Higashi E, Fukami T, Itoh M, et al. Human CYP2A6 is induced by estrogen via estrogen receptor. Drug Metab Dispos 2007;35(10):1935-41
37. Kawamoto T, Kakizaki S, Yoshinari K, et al. Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene. Mol Endocrinol 2000;14(11):1897-905
38. Yang K, Koh K, Choi S, et al. CAR (constitutive androstane/active receptor) -mediated up-regulation of CYP2B6 expression by 17 b-estradiol. Drug Metab Rev 2009;41(Suppl 3):89
39. Korenman SG. Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids 1969;13(2):163-77
40. Martucci C, Fishman J. Uterine estrogen receptor binding of catecholestrogens and of estetrol (1, 3, 5 (10) -estratriene-3, 15alpha, 16alpha, 17beta-tetrol). Steroids 1976;27(3):325-33
41. Visser M, Coelingh Bennink HJ. Clinical applications for estetrol. J Steroid Biochem Mol Biol 2009;114(1-2):85-9
42. Watson CS, Jeng YJ, Kochukov MY. Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation. FASEB J 2008;22(9):3328-36
43. Ekena K, Katzenellenbogen JA, Katzenellenbogen BS. Determinants of ligand specificity of estrogen receptor-alpha: estrogen versus androgen discrimination. J Biol Chem 1998;273(2):693-9
44. Gorodeski GI, Pal D. Involvement of estrogen receptors alpha and beta in the regulation of cervical permeability. Am J Physiol Cell Physiol 2000;278(4):C689-96
45. Hirano S, Furutama D, Hanafusa T. Physiologically high concentrations of 17beta-estradiol enhance NF-kappaB activity in human T cells. Am J Physiol Regul Integr Comp Physiol 2007;292(4):R1465-71
46. Attardi BJ, Zeleznik A, Simhan H, et al. Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins. Am J Obstet Gynecol 2007;197(6):599 e1-7
47. Thomas HV, Murphy MF, Key TJ, et al. Pregnancy and menstrual hormone levels in mothers of twins compared to mothers of singletons. Ann Hum Biol 1998;25(1):69-75
48. Potischman N, Troisi R, Thadhani R, et al. Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14(6):1514-20
49. Arslan AA, Zeleniuch-Jacquotte A, Lukanova A, et al. Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15(11):2123-30
50. Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 2002;143(1):205-12
51. Moyer DL, Felix JC. The effects of progesterone and progestins on endometrial proliferation. Contraception 1998;57(6):399-403
52. Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol 2008;83:1-10
53. O'Connell MB, Frye RF, Matzke GR, et al. Effect of conjugated equine estrogens on oxidative metabolism in middle-aged and elderly postmenopausal women. J Clin Pharmacol 2006;46(11):1299-307
54. Lamba V, Lamba J, Yasuda K, et al. Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther 2003;307(3):906-22
55. Zhang H, Wu X, Wang H, et al. Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course. Mol Pharmacol 2008;74(3):714-23 • Review of sex differences in DME expression.
56. Fuglsang J, Ovesen P. Aspects of placental growth hormone physiology. Growth Horm IGF Res 2006;16(2):67-85
57. Waxman DJ, O'Connor C. Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol 2006;20(11):2613-29
58. Waxman DJ, Holloway MG. Centennial perspective: sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009;76(2):215-28
59. Thangavel C, Garcia MC, Shapiro BH. Intrinsic sex differences determine expression of growth hormone-regulated female cytochrome P450s. Mol Cell Endocrinol 2004;220(1-2):31-9
60. Holloway MG, Miles GD, Dombkowski AA, et al. Liver-specific hepatocyte nuclear factor-4alpha deficiency: greater impact on gene expression in male than in female mouse liver. Mol Endocrinol 2008;22(5):1274-86
61. Dhir RN, Dworakowski W, Thangavel C, et al. Sexually dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone. J Pharmacol Exp Ther 2006;316(1):87-94
62. Liddle C, Goodwin BJ, George J, et al. Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 1998;83(7):2411-6
63. Sinues B, Mayayo E, Fanlo A, et al. Effects of growth hormone deficiency and rhGH replacement therapy on the 6beta-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children. Eur J Clin Pharmacol 2004;60(8):559-64
64. Cheung NW, Liddle C, Coverdale S, et al. Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man. J Clin Endocrinol Metab 1996;81(5):1999-2001
65. Jaffe CA, Turgeon DK, Lown K, et al. Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. Am J Physiol Endocrinol Metab 2002;283(5):E1008-15 • Clinical examination of the effects of GH pulsatility on CYP expression.
66. Jurgens G, Lange KH, Reuther LO, et al. Effect of growth hormone on hepatic cytochrome P450 activity in healthy elderly men. Clin Pharmacol Ther 2002;71(3):162-8
67. Forsyth IA, Wallis M. Growth hormone and prolactin-molecular and functional evolution. J Mammary Gland Biol Neoplasia 2002;7(3):291-312
68. Creasy RK, Resnik R, Iams JD. Maternal-fetal medicine: principles and practice. 5th edition.: Saunders, Philadelphia, PA, USA; 2004
69. Luquita MG, Catania VA, Sanchez-Pozzi EJ, et al. Prolactin increases the hepatic content of mu-class subunits of glutathione S-transferase in the rat. Drug Metab Dispos 1999;27(1):122-4
70. Luquita MG, Sanchez Pozzi EJ, Catania VA, et al. Analysis of p-nitrophenol glucuronidation in hepatic microsomes from lactating rats. Biochem Pharmacol 1994;47(7):1179-85
71. Luquita MG, Catania VA, Sanchez-Pozzi EJ, et al. Ovine prolactin increases hepatic UDP-glucuronosyltransferase activity in ovariectomized rats. J Pharmacol Exp Ther 1996;278(2):921-5
72. Luquita MG, Catania VA, Pozzi EJ, et al. Molecular basis of perinatal changes in UDP-glucuronosyltransferase activity in maternal rat liver. J Pharmacol Exp Ther 2001;298(1):49-56
73. Ganguly TC, O'Brien ML, Karpen SJ, et al. Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. Mediation of transcriptional activation by Stat5. J Clin Invest 1997;99(12):2906-14
74. Cao J, Gowri PM, Ganguly TC, et al. PRL, placental lactogen, and GH induce NA (+)/taurocholate-cotransporting polypeptide gene expression by activating signal transducer and activator of transcription-5 in liver cells. Endocrinology 2001;142(10):4212-22
75. Liu Y, Hyde JF, Vore M. Prolactin regulates maternal bile secretory function post partum. J Pharmacol Exp Ther 1992;261(2):560-6
76. Greenspan FS, Gardner DG. Basic & clinical endocrinology. 7th edition. Lange Medical Books/McGraw-Hill, New York; 2004
77. Gabbe SG, Niebyl JR, Simpson JL. Obstetrics: normal and problem pregnancies. 5th edition. Churchill Livingstone/Elsevier, Philadelphia, PA, USA; 2007
78. Soldin OP, Guo T, Weiderpass E, et al. Steroid hormone levels in pregnancy and 1 year postpartum using isotope dilution tandem mass spectrometry. Fertil Steril 2005;84(3):701-10
79. Pascussi JM, Gerbal-Chaloin S, Drocourt L, et al. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 2003;1619(3):243-53
80. LeCluyse E, Madan A, Hamilton G, et al. Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. J Biochem Mol Toxicol 2000;14(4):177-88
81. Pascussi JM, Drocourt L, Gerbal-Chaloin S, et al. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur J Biochem 2001;268(24):6346-58
82. Pascussi JM, Gerbal-Chaloin S, Fabre JM, et al. Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 2000;58(6):1441-50
83. Pascussi JM, Drocourt L, Fabre JM, et al. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 2000;58(2):361-72
84. Sugatani J, Nishitani S, Yamakawa K, et al. Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1. Mol Pharmacol 2005;67(3):845-55
85. Borlakoglu JT, Scott A, Henderson CJ, et al. Alterations in rat hepatic drug metabolism during pregnancy and lactation. Biochem Pharmacol 1993;46(1):29-36
86. Turcan RG, Tamburini PP, Gibson GG, et al. Drug metabolism, cytochrome P450 spin state, and phospholipid changes during pregnancy in the rat. Biochem Pharmacol 1981;30(11):1223-5
87. Neale MG, Parke DV. Effects of pregnancy on the metabolism of drugs in the rat and rabbit. Biochem Pharmacol 1973;22(12):1451-61
88. Vore M, Soliven E. Hepatic estrone and estradiol glucuronyltransferase activity in pregnancy. Induction by pretreatment with 3-methylcholanthrene and phenobarbital. Drug Metab Dispos 1979;7(5):247-51
89. He XJ, Yamauchi H, Suzuki K, et al. Gene expression profiles of drugmetabolizing enzymes (DMEs) in rat liver during pregnancy and lactation. Exp Mol Pathol 2007;83(3):428-34
90. Masuyama H, Hiramatsu Y, Mizutani Y, et al. The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse. Mol Cell Endocrinol 2001;172(1-2):47-56
91. Ochs H, Dusterberg B, Gunzel P, et al. Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. Cancer Res 1986;46(3):1224-32
92. First principles of gastroenterology: the basis of disease and an approach to management. 2nd edition. Ottawa, Ontario, Canada: Canadian Public Health Association; 1992
93. Shaikh AA. Estrone and estradiol levels in the ovarian venous blood from rats during the estrous cycle and pregnancy. Biol Reprod 1971;5(3):297-307
94. Dean ME, Stock BH. Hepatic microsomal metabolism of drugs during pregnancy in the rat. Drug Metab Dispos 1975;3(5):325-31
95. Graham MJ, Lake BG. Induction of drug metabolism: species differences and toxicological relevance. Toxicology 2008;254(3):184-91
96. Cunningham F, Levono K, Bloom S, et al. Williams obstetrics. 22nd edition. New York, USA: McGraw-Hill; 2005
97. Yallampalli C, Chauhan M, Thota CS, et al. Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity. Trends Endocrinol Metab 2002;13(6):263-9
98. Lambert GH, Lietz HW, Kotake AN. Effects of pregnancy on the cytochrome P-450 system in mice. Biochem Pharmacol 1987;36(12):1965-71